Werbung ausblenden

News zu Amplitude Surgical

Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of ¬83.8m, up +6.4% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical Announces H1 2024-25 Results: 51.5 M¬ Sales and 13.1 M¬ EBITDA · Uhr · Business Wire
Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of ¬51.5m, +6.3% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical - First Quarter 2024-25: Consolidated Sales of ¬21.8m, +7.5% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical Announces Its 2024-25 Financial Calendar · Uhr · Business Wire
Amplitude Surgical - Fiscal Year 2023-24: 106.0 M¬ Sales and ¬27.1m EBITDA · Uhr · Business Wire
Amplitude Surgical - Consolidated Annual Sales of ¬106.0m, up +6.3% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of ¬79.6m, up +6.1% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical Announces H1 2023-2024 Results: ¬49.1m Sales and ¬11.8m EBITDA · Uhr · Business Wire
Amplitude Surgical Announces Its 2023-24 Financial Calendar · Uhr · Business Wire
Amplitude Surgical - First quarter 2023-24: Consolidated Sales of ¬20.5m, +7.0% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical announces the closing of the sale of Novastep's activities · Uhr · Business Wire
Amplitude Surgical – H1 2021-22: Sales of €48.1m, +3.9% at Constant Exchange Rates · Uhr · Business Wire
Amplitude Surgical – First quarter 2021-22: Sales of €20.2 million, -7.1% at constant exchange rates · Uhr · Business Wire
Amplitude Surgical Announces Its 2021-22 Financial Calendar · Uhr · Business Wire
Amplitude Surgical – 2020-21 Annual Results: Sales of €95.5m and EBITDA of €20.6m · Uhr · Business Wire